Nwk Group, Inc. Ligand Pharmaceuticals Inc Transaction History
Nwk Group, Inc.
- $213 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding LGND
# of Institutions
233Shares Held
16.5MCall Options Held
77.9KPut Options Held
25K-
Black Rock Inc. New York, NY2.87MShares$263 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$173 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C31.03MShares$94.8 Million0.09% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$92.5 Million0.04% of portfolio
-
Stephens Investment Management Group LLC697KShares$63.9 Million0.7% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.55B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...